The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 101–200 of 1,000
Jinushi, M., Vanneman, M., Munshi, N. C., Tai, Y.-T., Prabhala, R. H., Ritz, J., Neuberg, D., Anderson, K. C., Carrasco, D. R., & Dranoff, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711293105 · Cited by 256
“However, MICA is commonly detected in solid and hematological malignancies (25–27), where it may be induced as part of the DNA damage response through ataxia telangiectasia mutated (ATM), ataxia telangiectasia mutated and Rad3-related (ATR), and checkpoint kinases 1 and 2 (chk-1 and -2) (28).”
BackgroundRegulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory Pathway
Lu, L., Ikizawa, K., Hu, D., Werneck, M. B. F., Wucherpfennig, K. W., & Cantor, H. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.017 · Cited by 253
“NK cells are equipped to recognize and lyse activated T cells (Rabinovich et al., 2003; Gasser et al., 2005), and interactions between NK cells and antigen-presenting cells may inhibit the activation of T helper cells (Gerosa et al.”
BackgroundOrth, J. D., Loewer, A., Lahav, G., & Mitchison, T. J. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-09-0781 · Cited by 253
“…DNA damage can result in the expression of ligands on the cell surface that in turn recruit natural killer cells to remove the damaged cells (Gasser et al., 2005) and p53-driven senescence can up-regulate inflammatory cytokine production, resulting in tumor clearance via innate immune…”
BackgroundRadiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
Lhuillier, C., Rudqvist, N.-P., Yamazaki, T., Zhang, T., Charpentier, M., Galluzzi, L., Dephoure, N., Clement, C. C., Santambrogio, L., Zhou, X. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138740 · Cited by 240
“Upregulation of Raet1e and Dhx58 expression is known to occur in irradiated cells (34, 35).”
BackgroundProteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Waldhauer, I., & Steinle, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2520 · Cited by 245
“NKG2DL expression is induced by carcinogens and genotoxic stress, and tumor cell lines transduced with mouse NKG2DL were readily eliminated in vivo due to NK and CD8 T-cell activity and induced tumor immunity against the parental cell line (6, 9, 10).”
BackgroundPhysiological and pathological consequences of cellular senescence
Burton, D. G. A., & Krizhanovsky, V. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1691-3 · Cited by 253
“tation of these ligands on senescent cells might be mediated by a DDR, which was previously shown to induce their expression [113].”
BackgroundNatural killer cells in infection and inflammation of the lung
Culley, F. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03167.x · Cited by 244
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Park, M. D., Reyes-Torres, I., LeBerichel, J., Hamon, P., LaMarche, N. M., Hegde, S., Belabed, M., Troncoso, L., Grout, J. A., Magen, A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01475-4 · Cited by 251
Radiation effects on antitumor immune responses: current perspectives and challenges
Walle, T., Martinez Monge, R., Cerwenka, A., Ajona, D., Melero, I., & Lecanda, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017742575 · Cited by 243
NKG2D ligands: key targets of the immune response
González, S., López-Soto, A., Suarez-Alvarez, B., López-Vázquez, A., & López-Larrea, C. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.007 · Cited by 241
Macrophages as mediators of tumor immunosurveillance
Jaiswal, S., Chao, M. P., Majeti, R., & Weissman, I. L. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.04.001 · Cited by 246
“13 Gasser, S. et al. (2005) The DNA damage pathway regulates innate”
BackgroundThe intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
Spiotto, M., Fu, Y.-X., & Weichselbaum, R. R. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag1266 · Cited by 239
“demonstrated that radiation and other genotoxic stress induced expression of ligands binding NKG2D, which was dependent of ATM, ataxia telangiectasia– and Rad3-related protein, or checkpoint kinase 1 (47).”
BackgroundActivation and self‐tolerance of natural killer cells
Gasser, S., & Raulet, D. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00460.x · Cited by 233
“Tumor cell lines were transduced with retroviral vectors encoding green fluorescence protein (GFP) and ATM siRNA or ATR siRNA or GFP and control siRNA, and were cultured for 7 days, splitting as necessary [using methods similar to those previously published (79)].”
BackgroundMethodSelf-citationInnate Immunity and Cancer Pathophysiology
Maiorino, L., Daßler-Plenker, J., Sun, L., & Egeblad, M. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-032221-115501 · Cited by 215
Development of PARP and immune-checkpoint inhibitor combinations
Stewart, R. A., Pilié, P. G., & Yap, T. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2652 · Cited by 239
“For example, studies of aphidicolin and cytarabine have shown the ability of DNA-damaging agents to drive upregulation of natural-killer group 2, member D ligands, inducible T-cell costimulator (ICOS) ligand and MHC class I, in an ATM- or ATR-dependent manner (76, 77).”
BackgroundDanger-associated molecular patterns in Alzheimer’s disease
Venegas, C., & Heneka, M. T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0416-204r · Cited by 236
“Examples of endogenous proteins and nucleic acids that act as DAMPs include IL-1, IL-33, HMGB1, Ab, chromogranin A, ASC, the S100 class of proteins, mt-DNA, nuclear DNA, ATP, uric acid, and ds- and ssRNA [4, 5].”
Diermayr, S., Himmelreich, H., Durovic, B., Mathys-Schneeberger, A., Siegler, U., Langenkamp, U., Hofsteenge, J., Gratwohl, A., Tichelli, A., Paluszewska, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-101311 · Cited by 220
“In epithelial tissue, the surface expression of NKG2D-L is upregulated in response to cellular stress including heat shock, DNA damage and stalled DNA replication, which are common in human cancer.(16,17) A notion that NKG2D-L play a key role as tumor-associated ligands rendering cells susceptible to NK-mediated lysis…”
BackgroundDesigning Cancer Immunotherapies That Engage T Cells and NK Cells
Kyrysyuk, O., & Wucherpfennig, K. W. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-044122 · Cited by 213
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
Thielens, A., Vivier, E., & Romagné, F. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.001 · Cited by 214
Eisele, G. (2006) · Brain · doi:10.1093/brain/awl205 · Cited by 219
Molecular mechanisms of natural killer cell activation in response to cellular stress
Chan, C. J., Smyth, M. J., & Martinet, L. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.26 · Cited by 213
“These findings have shown a critical direct link between cellular transformation, apoptosis, and surveillance by the immune system.62 The first evidence of this link between DNA damage and immune cell activation was provided by Raulet and colleagues who showed that NKG2D ligands were upregulated by genotoxic stress an…”
BackgroundInfluentialIdentification of the target self-antigens in reperfusion injury
Zhang, M., Alicot, E. M., Chiu, I., Li, J., Verna, N., Vorup-Jensen, T., Kessler, B., Shimaoka, M., Chan, R., Friend, D., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050390 · Cited by 221
Textor, S., Fiegler, N., Arnold, A., Porgador, A., Hofmann, T. G., & Cerwenka, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3211 · Cited by 221
“Several reports showed that triggering of the DNA damage response by agents that activate ATM (ataxia telangiectasia, mutated) and ATR (ATM- and Rad3-related) protein kinases led to elevated mRNA expression of certain NKG2D ligands (9, 25, 26).”
DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance
Ermolaeva, M. A., Segref, A., Dakhovnik, A., Ou, H.-L., Schneider, J. I., Utermöhlen, O., Hoppe, T., & Schumacher, B. (2013) · Nature · doi:10.1038/nature12452 · Cited by 221
The diverse consequences of aneuploidy
Chunduri, N. K., & Storchová, Z. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0243-8 · Cited by 210
Killers 2.0: NK cell therapies at the forefront of cancer control
Hodgins, J. J., Khan, S. T., Park, M. M., Auer, R. C., & Ardolino, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129338 · Cited by 217
“DNA damage from high-dose radiation and chemotherapy both led to increased expression of NKG2D ligands through an ATM- and ATR-dependent pathway (48).”
BackgroundNKG2D ligands as therapeutic targets.
(2013) · Europe PMC (PubMed Central) · Cited by 218
REVIEW ARTICLE: The Unique Properties of Uterine NK Cells
Manaster, I., & Mandelboim, O. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00794.x · Cited by 213
Processes of Sterile Inflammation
Shen, H., Kreisel, D., & Goldstein, D. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301539 · Cited by 209
“For example, DNA damage from tumorigenesis leads to the upregulation of NKG2D ligands, which are sensed by NKG2D receptors on NK cells and initiate antitumor immunity (22, 23).”
BackgroundOrigin and Consequences of Necroinflammation
Sarhan, M., Land, W. G., Tonnus, W., Hugo, C. P., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 207
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee, E. M., Dang, C. V., Agus, D. B., Alexander, B. M., Anderson, K. C., Ashworth, A., Barker, A. D., Bastani, R., Bhatia, S., Bluestone, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30698-8 · Cited by 208
How Do Natural Killer Cells Find Self to Achieve Tolerance?
Yokoyama, W. M., & Kim, S. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.006 · Cited by 206
Pfannstiel, C., Strissel, P. L., Chiappinelli, K. B., Sikic, D., Wach, S., Wirtz, R. M., Wullweber, A., Taubert, H., Breyer, J., Otto, W., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0758 · Cited by 212
“Platinum-containing chemotherapy has been shown to increase DCs, eliminate MDSCs (51), enhance NK-cell–mediated antitumor toxicity (52), and increase CD8þ TEFF-cell– mediated antitumor responses (53).”
BackgroundImmunogenic cell death modalities and their impact on cancer treatment
Kepp, O., Tesniere, A., Schlemmer, F., Michaud, M., Senovilla, L., Zitvogel, L., & Kroemer, G. (2009) · Apoptosis · doi:10.1007/s10495-008-0303-9 · Cited by 204
“This response can lead to the expression of ligands for the stimulatory immune receptor expressed by natural killer (NK) cells and T cells, NKG2D, such as MHC class I polypeptide-related sequence A (MICA) or the retinoic acid early transcript 1 (RAE1) [101].”
BackgroundWu, Y., Kyle-Cezar, F., Woolf, R. T., Naceur-Lombardelli, C., Owen, J., Biswas, D., Lorenc, A., Vantourout, P., Gazinska, P., Grigoriadis, A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax9364 · Cited by 199
“In relation to cancer, this is potentially important because NKG2D ligands are up-regulated by DNA damage (8) and EGFR overactivity (9).”
BackgroundLine of attack: NK cell specificity and integration of signals
Bryceson, Y. T., & Long, E. O. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.005 · Cited by 197
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
Baychelier, F., Sennepin, A., Ermonval, M., Dorgham, K., Debré, P., & Vieillard, V. (2013) · Blood · doi:10.1182/blood-2013-03-489054 · Cited by 186
DNA Damage Response and Immune Defense: Links and Mechanisms
Nakad, R., & Schumacher, B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00147 · Cited by 195
“Moreover, siRNA knock-down of ATM in tumor cell lines abrogated NKG2D ligand expression (Gasser et al., 2005).”
BackgroundTricking the balance: NK cells in anti-cancer immunity
Pahl, J., & Cerwenka, A. (2017) · Immunobiology · doi:10.1016/j.imbio.2015.07.012 · Cited by 205
“These ligands are normally not expressed on healthy cells under non-inflammatory conditions but can be induced, for instance, in response to DNA damage as demonstrated for NKG2D ligands (Gasser et al., 2005).”
BackgroundWenzel, J., & Tüting, T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.96 · Cited by 203
Paschen, A., Sucker, A., Hill, B., Moll, I., Zapatka, M., Nguyen, X. D., Sim, G. C., Gutmann, I., Hassel, J., Becker, J. C., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0886 · Cited by 192
“Genetic alterations can initiate an intrinsic DNA damage response that in turn induces the expression of surface ligands binding to the activating immunoreceptor NKG2D (1).”
Backgroundγδ T Cell Update: Adaptate Orchestrators of Immune Surveillance
Hayday, A. C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800934 · Cited by 196
“NKG2D ligands Rae-1 (mouse) or MICA/ULBP (human) are strong candidates for DAMPs in human carcinoma because they are upregulated by DNA damage and by hyperactive epithelial growth factor receptor signaling (84, 85).”
BackgroundCancers Related to Immunodeficiencies: Update and Perspectives
Mortaz, E., Tabarsi, P., Mansouri, D., Khosravi, A., Garssen, J., Velayati, A., & Adcock, I. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00365 · Cited by 190
Chemo-Immunotherapy: A New Trend in Cancer Treatment
Sordo-Bahamonde, C., Lorenzo-Herrero, S., Gonzalez-Rodriguez, A. P., Martínez-Pérez, A., Rodrigo, J. P., García-Pedrero, J. M., & Gonzalez, S. (2023) · Cancers · doi:10.3390/cancers15112912 · Cited by 176
“This upregulation promotes NK cell-mediated cytotoxicity and IFN-γ release, which subsequently favors the upregulation of MHC class I molecules on tumor cells, sensitizing them to CTLs (Figure 1) [40].”
BackgroundKim, J.-Y., Son, Y.-O., Park, S.-W., Bae, J.-H., Chung, J. S., Kim, H. H., Chung, B.-S., Kim, S.-H., & Kang, C.-D. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.56 · Cited by 195
“Recently, it has been shown that mouse and human NKG2D ligands are upregulated by genotoxic stress, and ligand upregulation is prevented by pharmacological or genetic inhibition of ATR (ATM- and Rad3-related), ATM (ataxia telangiectasia, mutated) or Chk1 (a downstream transducer kinase in the pathway) (Gasser et al.,…”
BackgroundMcGilvray, R. W., Eagle, R. A., Watson, N. F. S., Al-Attar, A., Ball, G., Jafferji, I., Trowsdale, J., & Durrant, L. G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0991 · Cited by 196
“Some stimuli have been reported to result in the expression of all NKG2D ligands tested, such as DNA damage responses in mice (15).”
BackgroundWard, J., Bonaparte, M., Sacks, J., Guterman, J., Fogli, M., Mavilio, D., & Barker, E. (2007) · Blood · doi:10.1182/blood-2006-06-028175 · Cited by 190
Interplay between DNA repair and inflammation, and the link to cancer
Kidane, D., Chae, W. J., Czochor, J., Eckert, K. A., Glazer, P. M., Bothwell, A. L. M., & Sweasy, J. B. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.875514 · Cited by 186
“DNA damaging agents and replication inhibitors also upregulate the expression of NKG2D ligands in an ATM dependent manner (Gasser et al., 2005).”
BackgroundCytokine regulation of natural killer cell effector functions
Zwirner, N. W., & Domaica, C. I. (2010) · BioFactors · doi:10.1002/biof.107 · Cited by 182
“[30] Gasser, S.”
BackgroundVenkataraman, G. M., Suciu, D., Groh, V., Boss, J. M., & Spies, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.961 · Cited by 191
“Recent evidence has indicated that activation of DNA damage control pathways results in induction of NKG2D ligands, including UL16-binding protein family members and possibly MICA (10).”
BackgroundCancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy
Liu, Y., & Zeng, G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182518e83 · Cited by 185
Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
Ruocco, M. G., Pilones, K. A., Kawashima, N., Cammer, M., Huang, J., Babb, J. S., Liu, M., Formenti, S. C., Dustin, M. L., & Demaria, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61931 · Cited by 187
“In addition, genotoxic stress, such as induced by IR, regulates the expression of NKG2D ligands on normal and transformed cells (37, 38).”
Heinemann, A., Zhao, F., Pechlivanis, S., Eberle, J., Steinle, A., Diederichs, S., Schadendorf, D., & Paschen, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1977 · Cited by 187
“Previously, Gasser and colleagues showed an induction of ULBP2 expression in response to DNA damage in HCT116 p53þ/þ and HCT116 p53 / cells indicating that under these conditions activated p53 neither downregulated ULBP2 nor was it required for NKG2DL induction (19).”
BackgroundTumor and viral recognition by natural killer cells receptors
Arnon, T. I., Markel, G., & Mandelboim, O. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.005 · Cited by 178
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Lam, A. R., Le Bert, N., Ho, S. S. W., Shen, Y. J., Tang, M. L. F., Xiong, G. M., Croxford, J. L., Koo, C. X., Ishii, K. J., Akira, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1703 · Cited by 179
“The late kinetics of IRF3S388 phosphorylation were similar to kinetics previously observed for DNA damage–induced upregulation of NKG2DLs (6).”
InfluentialSelf-citationCerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., Santoni, A., & Doria, M. (2007) · Journal of General Virology · doi:10.1099/vir.0.82125-0 · Cited by 177
“Cellsurface expression of MIC proteins, which is normally restricted to the gastrointestinal epithelium, can be induced by tumour transformation, heat shock, DNA damage, and infection by Mycobacterium tuberculosis, Escherichia coli and cytomegalovirus (CMV) (Gasser et al., 2005; Lodoen & Lanier, 2005).”
BackgroundInfluentialNatural killer cells: role in local tumor growth and metastasis
Jacobs, N., Langers, Renoux, Thiry, & Delvenne (2012) · Biologics: Targets and Therapy · doi:10.2147/btt.s23976 · Cited by 163
“activating ligand (eg, NKG2DL) expression via DNA damage response.(119) Figure 4 summarizes the different mechanisms implicated into NK cell response against tumor cells.”
The immune mechanisms of abscopal effect in radiation therapy
Grass, G. D., Krishna, N., & Kim, S. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.10.003 · Cited by 175
The DNA Damage Response Arouses the Immune System
Gasser, S., & Raulet, D. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4603 · Cited by 178
“In summary, we recently provided evidence that expression of NKG2D ligands is induced in untransformed mouse cells by agents that damage the DNA or impart DNA replication stress, but not by other common forms of stress (14).”
BackgroundInfluentialSelf-citationKrockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 179
“These ligands (MICA/B, ULBP1-4) are induced by DNA damage (29) and are found on virus-infected and tumor cells (30–32).”
BackgroundPeng, Y.-P., Zhu, Y., Zhang, J.-J., Xu, Z.-K., Qian, Z.-Y., Dai, C.-C., Jiang, K.-R., Wu, J.-L., Gao, W.-T., Li, Q., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-262 · Cited by 172
“In patients with cancer, NKG2D generally binds specifically to killer cell lectin-like receptor subfamily K, member 1 ligands (NKG2DLs) expressed on transformed malignant cells, such as MHC class I-related molecules, MHC class I polypeptide-related sequence A/B (MICA/MICB), and UL16-binding protein (ULBP) [30].”
BackgroundPaolini, R., Bernardini, G., Molfetta, R., & Santoni, A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.003 · Cited by 171
“histotypes, infected, and stressed cells, and can be induced in response to DNA damage [7,8].”
BackgroundContinuous engagement of a self-specific activation receptor induces NK cell tolerance
Tripathy, S. K., Keyel, P. A., Yang, L., Pingel, J. T., Cheng, T. P., Schneeberger, A., & Yokoyama, W. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072446 · Cited by 176
Role of T lymphocytes in tumor response to radiotherapy
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00095 · Cited by 174
“M., Feltri, M., Bertolini, V., Bagnoli, E., Furlan, D., Cerutti, R., Novario, R., and Capella, C. (2006). Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.”
BackgroundInfluentialBinyamin, L., Alpaugh, R. K., Hughes, T. L., Lutz, C. T., Campbell, K. S., & Weiner, L. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6392 · Cited by 176
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Sato, H., Okonogi, N., & Nakano, T. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01666-1 · Cited by 173
Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?
Vivier, E., Spits, H., & Cupedo, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2522 · Cited by 172
“Cell-surface ligands for NKG2D are upregulated by transformed, infected or distressed cells, partly as a result of initiation of the DNA damage respons”
BackgroundNK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen
Roy, S., Barnes, P. F., Garg, A., Wu, S., Cosman, D., & Vankayalapati, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1729 · Cited by 169
“Treatment of mouse T cell blasts with a DNA-damaging agent increases NKG2D ligand expression, and increased expression correlates with NKG2D-dependent lysis by IL-2-activated NK cells (48).”
BackgroundCancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity
Ménard, C., Martin, F., Apetoh, L., Bouyer, F., & Ghiringhelli, F. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0505-6 · Cited by 167
“DNA damage triggers tumor cells to express ligand for NKG2D, an activating receptor of NK, NKT, T cell components of the innate immune system that could trigger a Th1 immune response [60].”
BackgroundRichard, J., Sindhu, S., Pham, T. N. Q., Belzile, J.-P., & Cohen, É. A. (2010) · Blood · doi:10.1182/blood-2009-08-237370 · Cited by 164
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Shevtsov, M., Sato, H., Multhoff, G., & Shibata, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00156 · Cited by 173
“In contrast to the involvement of T cell-dependent immune responses after DNA damage, previous studies demonstrated that NKG2D ligands in cancer cells are also upregulated after DNA damage in a Chk1-dependent manner (70, 71).”
ResultNK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion
Morandi, B., Bougras, G., Muller, W. A., Ferlazzo, G., & Münz, C. (2006) · European Journal of Immunology · doi:10.1002/eji.200636290 · Cited by 164
Jinushi, M., Hodi, F. S., & Dranoff, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603503103 · Cited by 168
Regulation of ligands for the activating receptor NKG2D
Mistry, A. R., & O'Callaghan, C. A. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02652.x · Cited by 160
Radiation as an Immune Modulator
Burnette, B., & Weichselbaum, R. R. (2013) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.05.009 · Cited by 165
Le, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
“As a possible explanation for our results, we were unable to detect increased expression of mouse NKG2D ligands (Rae-1 and Mult-1) in irradiated cells or tissues, in contrast to expectations (Gasser et al., 2005).”
BackgroundResultInfluentialDeguine, J., Bréart, B., Lemaître, F., Santo, J. P. D., & Bousso, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.016 · Cited by 179
Keep calm: the intestinal barrier at the interface of peace and war
Thoo, L., Noti, M., & Krebs, P. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2086-z · Cited by 159
Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
Fernández‐Messina, L., Ashiru, O., Boutet, P., Agüera‐González, S., Skepper, J. N., Reyburn, H. T., & Valés‐Gómez, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045906 · Cited by 182
Fas ligand–mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity
Groh, V., Smythe, K., Dai, Z., & Spies, T. (2006) · Nature Immunology · doi:10.1038/ni1350 · Cited by 167
“NKG2D interacts with major histocompatibility complex (MHC) class I–like ligands that are not involved in antigen presentation but can be induced by cellular and genotoxic stress and are expressed in malignancies and some infection”
BackgroundSignal Transduction During Activation and Inhibition of Natural Killer Cells
Watzl, C., & Long, E. O. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109bs90 · Cited by 165
Nachmani, D., Lankry, D., Wolf, D. G., & Mandelboim, O. (2010) · Nature Immunology · doi:10.1038/ni.1916 · Cited by 158
Transplantation and Damage-Associated Molecular Patterns (DAMPs)
Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13963 · Cited by 163
Self-citationMuñoz, D. P., Yannone, S. M., Daemen, A., Sun, Y., Vakar-Lopez, F., Kawahara, M., Freund, A. M., Rodier, F., Wu, J. D., Desprez, P.-Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124716 · Cited by 162
Self-citationImproving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
Hoeres, T., Smetak, M., Pretscher, D., & Wilhelm, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00800 · Cited by 154
“The expression of NKG2D ligands (NKG2DL) is induced or upregulated primarily in tissues of epithelial origin, as a result of cellular stresses such as viral infection, malignant transformation, or classical heat shock (172, 173).”
BackgroundNK Cells in the Tumor Microenvironment
Guillerey, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_4 · Cited by 174
Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy
Huang, J., Yang, B., Peng, Y., Huang, J., Wong, S. H. D., Bian, L., Zhu, K., Shuai, X., & Han, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202011171 · Cited by 157
Matta, J., Baratin, M., Chiche, L., Forel, J.-M., Cognet, C., Thomas, G., Farnarier, C., Piperoglou, C., Papazian, L., Chaussabel, D., et al. (2013) · Blood · doi:10.1182/blood-2013-01-481705 · Cited by 151
“or proteasomes inhibitors that have been shown to induced cellsurface NKG2D ligands.(28,29) On the similarities, TLR signaling has been shown to upregulate transcription and expression of NKG2D ligands, such as retinoic acid early inducible-1 (RAE-1) familymembers in mouse macrophages(30) and MICA on human macrophages.”
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer
Nobre, C. C. G., de Araújo, J. M. G., Fernandes, T. A. A. D. M., Cobucci, R. N. O., Lanza, D. C. F., Andrade, V. S., & Fernandes, J. V. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-016-0138-6 · Cited by 159
“The ability of NK and TCD8+ cells to eliminate malignant cells depends on the recognition of stress- or transformationinduced molecules that bind to receptor NK group 2D (NKG2D; 4) to activate NK and TCD8+ cells [89, 90].”
BackgroundImmunosurveillance and therapy of multiple myeloma are CD226 dependent
Guillerey, C., Ferrari de Andrade, L., Vuckovic, S., Miles, K., Ngiow, S. F., Yong, M. C. R., Teng, M. W. L., Colonna, M., Ritchie, D. S., Chesi, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77181 · Cited by 152
“Moreover, therapeutic agents commonly used in the management of MM, such as melphalan and bortezomib (Btz), upregulate CD226 ligands and sensitize MM cells to NK cell–mediated cytotoxicity (25, 26).”
Boissel, N., Rea, D., Tieng, V., Dulphy, N., Brun, M., Cayuela, J.-M., Rousselot, P., Tamouza, R., Le Bouteiller, P., Mahon, F.-X., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.5108 · Cited by 148
“ataxia-telangiectasia-mutated (ATM) and ATM- and Rad-3-related protein kinases (15).”
BackgroundInfluentialNKG2D Ligands in Tumor Immunity: Two Sides of a Coin
Zhang, J., Basher, F., & Wu, J. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00097 · Cited by 146
“Ectopic expression of NKG2D ligands on diverse tumor cell lines resulted in tumor rejection in experimental animal models through activation of NK cells and in some cases CD8 T cells (7, 9, 10, 52).”
BackgroundThe Intraepithelial T Cell Response to NKG2D-Ligands Links Lymphoid Stress Surveillance to Atopy
Strid, J., Sobolev, O., Zafirova, B., Polic, B., & Hayday, A. (2011) · Science · doi:10.1126/science.1211250 · Cited by 155
A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease
Fang, M., Lanier, L. L., & Sigal, L. J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040030 · Cited by 151
“Identified cellular ligands for NKG2D in mice include H60, MULT1, and Rae-1 [45–49].”
BackgroundLeveraging NKG2D Ligands in Immuno-Oncology
Fuertes, M. B., Domaica, C. I., & Zwirner, N. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713158 · Cited by 166
Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy
Prajapati, K., Pérez, C., Plaza-Rojas, L., Burke, B., & Guevara-Patino, J. A. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.161 · Cited by 164
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Badrinath, S., Dellacherie, M. O., Li, A. W., Zheng, S., Zhang, X., Sobral, M. C., Pyrdol, J. W., Smith, K. L., Lu, Y., Haag, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04772-4 · Cited by 156
Chapter 2 Natural Killer Cell Tolerance
Jonsson, A. H., & Yokoyama, W. M. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)01002-x · Cited by 170
NK Cells Are Effectors for Resolvin E1 in the Timely Resolution of Allergic Airway Inflammation
Haworth, O., Cernadas, M., & Levy, B. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004007 · Cited by 158
“Because multiple ligands for the NKG2D receptor are upregulated during inflammation and cellular stress (18), their expression was measured using an NKG2DFc fusion protein (19).”
MethodFigueiredo, C. R., Kalirai, H., Sacco, J. J., Azevedo, R., Duckworth, A. D., Slupsky, J. R., Coulson, J. M., & Coupland, S. E. (2020) · The Journal of Pathology · doi:10.1002/path.5384 · Cited by 168
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.